Latest California Healthline Stories
Readers Have Bones To Pick, From Health System Flaws To Covering Marijuana Beat
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Podcast: ‘What The Health?’ While You Were Celebrating …
In this episode of “What The Health?” Julie Rovner of Kaiser Health News, Paige Winfield Cunningham of The Washington Post, Alice Ollstein of Talking Points Memo and Margot Sanger-Katz of The New York Times discuss this week’s news, including release of the administration’s new rules on association health plans, as well as some health-related court rulings and other events that happened around the holidays.
Biosimilars, Biologics And New Legal Challenges For RA Treatments
As biosimilar products reach the market and rival more established RA treatments, the players are exploring legal challenges involving antitrust and anti-competitive behavior.
No Sweeteners Added To Tax Bill To Spread Use Of Health Savings Accounts
These accounts are exempt from taxes and linked to high-deductible health plans. Republicans tried last summer in their unsuccessful efforts to replace the health law to make the accounts more enticing for consumers, but they didn’t make those changes in the current tax bill.
Podcast: ‘What The Health?’ Is Health Care Spending Still The Hungry, Hungry Hippo?
In this episode of “What the Health?” Julie Rovner of Kaiser Health News, Stephanie Armour of the Wall Street Journal, Alice Ollstein of Talking Points Memo and Margot Sanger Katz of The New York Times discuss new health spending numbers from the federal government, as well as how the year-end legislating in Congress is being complicated by health issues.
Your Plumber Offers A Money-Back Guarantee. Should Your Doctor?
Even though consumers don’t expect to pay for faulty service or goods, they are often forced to pay for bad health care. But a small number of hospitals and doctors are seeking to change that practice.
Patients With Rare Diseases And Congress Square Off Over Orphan Drug Tax Credits
The House and Senate want to reduce or eliminate federal tax credits for “orphan drugs” used to treat rare diseases, but patients are fighting against the plan.
The Ratcheting Price Of The Pneumococcal Vaccine: What Gives?
The price for Pfizer’s Prevnar 13 has increased 5 to 6 percent each year since its 2010 approval by the Food and Drug Administration.
Heated And Deep-Pocketed Battle Erupts Over 340B Drug Discount Program
Drugmakers, hospitals and lawmakers are taking sides in a showdown over a discount program that covers drug purchases at some hospitals.
Parents Are Not Liable For Medical Debts Of Adult Children On Shared Insurance
Even though the federal health law allows young adults to stay on their parents’ plan, those children are generally responsible for their own debts.